heading lower, page-3

Hyperon,

PTD is dishing out around 67.5m shares to EGX holders plus 15c per share.
Using your value for the company (about $260m including DCF of earnings plus current cash);

164m + 67.5m = 231.5m shares

$260m / 231.5m shares = $1.12

Minus the 15c extra per share = about $1.00.

This is valuing EGX and current pipeline at $0. But of course, they are not worth nothing.

I believe $1.00 should be about the base price. I reckon it will keep heading this way until some good news comes out.
Same old problem with biotechs; how do you value potential??

I will probably think about getting in at $1.20 - $1.30. This is based on simple calculation of diluting the pre-takeover hype price for both and diluting it by the number of shares on issue. In other words, I am assuming the old price a few months ago was fair enough for the market so it might be fair enough again. I also thick 20-30c is fair value for their intellectual property given what they sold domantis for.
Risky stuff.

whatdaya yeckon?